Related Experiment Video
Updated: Sep 28, 2025

04:40
Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
Published on: November 4, 2022
1.2K
Multifocal hepatic small vessel neoplasm with spleen dissemination
Carlo Maria Cicala1, Federico Monaca2, Maria Cristina Giustiniani3
1Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy carlom.cicala@gmail.com.
BMJ Case Reports
|March 30, 2022
Summary
Hepatic small vessel neoplasm (HSVN) is a rare liver tumor. This report details a unique case of multifocal HSVN with spleen metastasis, expanding knowledge on its potential for dissemination.
Area of Science:
- Hepatology
- Vascular Oncology
- Pathology
Background:
- Hepatic small vessel neoplasm (HSVN) is a recently identified, rare, infiltrative vascular tumor of the liver.
- The malignant potential and metastatic capacity of HSVN remain largely undetermined, with limited cases reported.
- Current literature primarily describes asymptomatic, solitary liver lesions, with multifocal disease being uncommon.
Observation:
- This report presents a rare case of multifocal hepatic small vessel neoplasm.
- The patient exhibited synchronous secondary lesions in the spleen, indicating potential for extrahepatic dissemination.
- This observation challenges the previously understood limited spread of HSVN.
Findings:
- The case demonstrates multifocal hepatic small vessel neoplasm.
- Synchronous spleen metastases were identified, representing the first reported instance of HSVN dissemination to another organ.
- This finding suggests a higher malignant potential for HSVN than previously recognized.
Implications:
- This case expands the understanding of hepatic small vessel neoplasm's behavior and metastatic potential.
- It highlights the importance of considering HSVN in the differential diagnosis of liver vascular lesions, especially in multifocal presentations.
- Further research is warranted to elucidate the oncogenesis and clinical management of HSVN with metastatic potential.

